Impact Factor
4.88
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
9.84
8,413 total citations
h5-index
103
h5 depth signal
Cited share
95.7%
872 of 911
Total citations
8,413
Citation footprint
Metric signal
9.51
External metric anchor
Self-citation
1.9%
163 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,863
China
1,123
United Kingdom
712
Germany
647
Canada
354
Citing Fields of Research
Psychiatry
2,329
Neurosciences
2,125
Genetics & Genomics
911
Neurodevelopmental Disorders
572
Neurodegenerative Disorders
518
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
5,723
Articles tracked across the journal lifetime
Indexed publication set
911
872 cited publications
Last 12 months
906
75.5 publications/month
Open access share
100.0%
906 OA publications in the last year
Leading citing country
United States
1,863 citing publications
Leading citing field
Psychiatry
2,329 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v1, April 2011-
v1n4, 2011-
Active Coverage
Research Focus & Classification
Indexed Subjects
Neurosciences
Psychiatry
Neurodegenerative Disorders
Neurodevelopmental Disorders
Broad Categories
Psychiatry
Neurosciences
Psychiatry
Genetics & Genomics
Neurodevelopmental Disorders
Substance Abuse
MeSH Descriptors
Health Policy
Neurosciences
Psychiatry
Public Health
Translational Research, Biomedical.
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1038/s41398-026-04533-1
Open DOI
Distinct cocaine- and shock-responsive ensembles in the nucleus accumbens
02
DOI 10.1038/s41398-026-04402-x
Open DOI
Predicting trail-making test performance using 7-Tesla structural cerebral MRI
Psychopharmaceutical therapy has seen a lack of improvement in efficacy, highlighting the need for a more individualized treatment approach that optimally leverages pharmaceutical effects. To achieve this, it is necessary to identify fac...
03
04
DOI 10.1038/s41398-026-04525-1
Open DOI
Ketamine induces synaptic and monoaminergic remodeling in human iPSC-derived neurons
Major depressive disorder (MDD) is a leading cause of global disability, and a substantial proportion of patients develop treatment-resistant depression (TRD), highlighting the urgent need for mechanistically novel and fast-acting antide...
05
06
DOI 10.1038/s41398-026-04502-8
Open DOI
Blunted cerebello-basal ganglia-thalamic circuit connectivity in melancholic depression
07
DOI 10.1038/s41398-026-04468-7
Open DOI
Epigenetic signatures of different types of childhood maltreatment in a high-risk sample: a preregistered replication study
Childhood maltreatment (CM) has long-lasting effects on physical and mental health with CM type specific effects being reported. Epigenetic processes, like deoxyribonucleic acid methylation (DNAm), might mediate this link, and CM types m...
08
09
DOI 10.1038/s41398-026-04498-1
Open DOI
A genetically informed investigation into the relationship between childhood maltreatment and adult health
10
DOI 10.1038/s41398-026-04523-3
Open DOI
Cumulative burden of adverse childhood experiences (ACEs) and non-adherence to breast cancer screening: A dose-response and network intervention analysis
Adverse childhood experiences (ACEs) are established determinants of adult health behaviors, yet their specific impact on cancer screening adherence remains under-explored. Understanding how distinct ACE patterns interact to hinder scree...